The University of Chicago Header Logo

Elizabeth Blair

Concepts (371)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
25
2022
1058
1.650
Why?
Carcinoma, Squamous Cell
19
2019
1065
1.590
Why?
Salivary Gland Neoplasms
5
2019
65
1.370
Why?
Carcinoma, Mucoepidermoid
2
2019
17
1.360
Why?
Otolaryngology
2
2023
57
1.280
Why?
Chemoradiotherapy
14
2022
305
1.060
Why?
Neoplasm Recurrence, Local
13
2022
1257
0.970
Why?
Otolaryngologists
1
2023
4
0.950
Why?
Actinomycosis
1
2022
12
0.910
Why?
Antineoplastic Combined Chemotherapy Protocols
20
2022
2390
0.890
Why?
Larynx
1
2022
39
0.890
Why?
Oropharyngeal Neoplasms
6
2022
124
0.850
Why?
Perforator Flap
1
2020
12
0.770
Why?
Paranasal Sinus Diseases
2
2018
24
0.730
Why?
Mouth Neoplasms
7
2018
196
0.730
Why?
Gene Rearrangement
2
2019
169
0.720
Why?
Papillomavirus Infections
5
2022
243
0.680
Why?
Neoplasm Grading
1
2019
336
0.660
Why?
Laryngeal Diseases
2
2015
19
0.640
Why?
Nose Diseases
1
2017
10
0.640
Why?
Nose Neoplasms
1
2017
31
0.640
Why?
Nasal Cavity
1
2017
91
0.610
Why?
Maxillary Sinus
2
2018
26
0.610
Why?
Trans-Activators
1
2019
428
0.590
Why?
Paranasal Sinus Neoplasms
1
2016
24
0.570
Why?
Aspergillosis
1
2016
40
0.560
Why?
Cementoma
1
2015
2
0.560
Why?
Mandibular Neoplasms
1
2015
24
0.540
Why?
Sarcoidosis
1
2015
67
0.530
Why?
Papillomaviridae
4
2022
155
0.510
Why?
Laryngeal Neoplasms
5
2017
89
0.500
Why?
Female
53
2023
43741
0.470
Why?
Humans
72
2023
83872
0.470
Why?
Sjogren's Syndrome
3
2009
29
0.470
Why?
Salivary Glands, Minor
2
2009
9
0.460
Why?
Middle Aged
43
2022
24690
0.460
Why?
Aged, 80 and over
21
2020
6453
0.440
Why?
Biomarkers, Tumor
2
2022
1440
0.430
Why?
Male
50
2023
40238
0.420
Why?
Adult
40
2023
25203
0.410
Why?
Airway Management
1
2012
45
0.410
Why?
Carcinoma
3
2022
427
0.380
Why?
Placenta
1
2011
169
0.380
Why?
Aged
34
2020
18097
0.370
Why?
Anesthesiology
1
2012
152
0.370
Why?
Quinazolines
4
2012
217
0.360
Why?
Hydroxyurea
10
2022
239
0.360
Why?
Leukoplakia, Oral
2
2023
10
0.360
Why?
Induction Chemotherapy
6
2022
147
0.350
Why?
Disease-Free Survival
15
2020
1203
0.330
Why?
Fluorouracil
10
2022
549
0.320
Why?
Neck
2
2020
98
0.310
Why?
Head
2
2020
130
0.310
Why?
Radiotherapy, Intensity-Modulated
5
2016
182
0.300
Why?
Clinical Competence
1
2012
746
0.290
Why?
Anti-Bacterial Agents
3
2022
702
0.280
Why?
Radiotherapy Dosage
11
2020
488
0.280
Why?
Warts
2
2019
11
0.270
Why?
Paclitaxel
6
2022
458
0.270
Why?
Tongue Neoplasms
4
2018
52
0.260
Why?
ErbB Receptors
4
2016
480
0.260
Why?
Diagnosis, Differential
4
2017
1535
0.260
Why?
Nasopharyngeal Neoplasms
2
2016
46
0.260
Why?
Treatment Outcome
17
2022
7776
0.240
Why?
Antineoplastic Agents
6
2012
2324
0.240
Why?
Oral and Maxillofacial Surgeons
1
2023
4
0.240
Why?
Alphapapillomavirus
2
2021
48
0.240
Why?
Irritants
1
2022
4
0.230
Why?
Pharynx
1
2022
46
0.230
Why?
Neoplasm Staging
12
2016
1931
0.230
Why?
Re-Irradiation
1
2022
16
0.220
Why?
HIV-1
1
2023
140
0.220
Why?
Laryngostenosis
1
2021
16
0.210
Why?
Tracheal Stenosis
1
2021
23
0.210
Why?
Drug Monitoring
1
2022
117
0.200
Why?
DNA, Viral
1
2022
263
0.200
Why?
Carcinoma, Papillary, Follicular
1
2020
13
0.200
Why?
Cell-Free Nucleic Acids
1
2022
60
0.200
Why?
Respiratory System
1
2021
116
0.200
Why?
Anti-HIV Agents
1
2023
139
0.200
Why?
In Situ Hybridization, Fluorescence
2
2019
348
0.200
Why?
Follow-Up Studies
13
2019
3603
0.190
Why?
ras Proteins
1
2020
128
0.190
Why?
United States
7
2023
6425
0.190
Why?
Proto-Oncogene Proteins B-raf
1
2020
136
0.190
Why?
Lymph Nodes
2
2016
527
0.190
Why?
Risk Factors
8
2019
5301
0.180
Why?
Smoking
3
2014
600
0.180
Why?
Cetuximab
2
2019
114
0.180
Why?
Practice Guidelines as Topic
2
2017
1033
0.180
Why?
Young Adult
6
2022
5843
0.180
Why?
Thyroid Neoplasms
2
2020
400
0.180
Why?
Prognosis
9
2022
3617
0.180
Why?
Arteries
1
2020
169
0.180
Why?
Radiation Dosage
1
2020
223
0.180
Why?
Retrospective Studies
15
2018
8061
0.180
Why?
Heterocyclic Compounds
1
2019
17
0.180
Why?
Maximum Tolerated Dose
4
2022
270
0.180
Why?
Immunologic Deficiency Syndromes
1
2019
47
0.180
Why?
Combined Modality Therapy
9
2016
1645
0.170
Why?
Receptors, CXCR4
1
2019
41
0.170
Why?
Bone Cysts, Aneurysmal
1
2018
7
0.170
Why?
Lip
2
2009
16
0.170
Why?
Precancerous Conditions
2
2016
194
0.170
Why?
Carboplatin
4
2022
286
0.170
Why?
Deglutition
3
2020
68
0.170
Why?
Dental Alloys
1
2018
6
0.170
Why?
Ubiquitin Thiolesterase
1
2018
57
0.170
Why?
Orthodontic Appliances
1
2018
8
0.170
Why?
Erlotinib Hydrochloride
2
2016
90
0.160
Why?
Inflammation
2
2017
875
0.160
Why?
Child
6
2019
6706
0.160
Why?
Adolescent
7
2022
8806
0.160
Why?
Glottis
1
2017
12
0.160
Why?
Mammary Analogue Secretory Carcinoma
1
2017
4
0.160
Why?
Surveys and Questionnaires
2
2023
2414
0.160
Why?
Bone Marrow
1
2019
430
0.150
Why?
Life Style
1
2018
184
0.150
Why?
Hypopharyngeal Neoplasms
2
2011
15
0.150
Why?
Prospective Studies
7
2022
4090
0.150
Why?
Fibrosis
1
2017
194
0.150
Why?
Transcriptome
1
2020
546
0.150
Why?
Professionalism
1
2016
24
0.140
Why?
Time Factors
4
2019
5176
0.140
Why?
Neoplasm Invasiveness
3
2016
522
0.140
Why?
Fibroma, Ossifying
1
2015
5
0.140
Why?
Anticarcinogenic Agents
1
2016
70
0.140
Why?
Guideline Adherence
1
2017
224
0.140
Why?
Gene Expression Regulation, Neoplastic
1
2020
1181
0.140
Why?
Premedication
1
1995
54
0.140
Why?
Pleural Neoplasms
1
2017
184
0.140
Why?
Simulation Training
1
2016
88
0.130
Why?
Predictive Value of Tests
1
2019
1636
0.130
Why?
HIV Infections
1
2023
725
0.130
Why?
Cerebellopontine Angle
1
1994
7
0.130
Why?
Ulnar Nerve
1
1994
6
0.130
Why?
Neuroma, Acoustic
1
1994
20
0.130
Why?
Tumor Virus Infections
1
2014
81
0.130
Why?
Neuromuscular Blocking Agents
1
1994
28
0.120
Why?
Facial Nerve
1
1994
33
0.120
Why?
Aminolevulinic Acid
1
2013
21
0.120
Why?
Photosensitizing Agents
1
2013
47
0.120
Why?
Biopsy
4
2009
1139
0.120
Why?
Monitoring, Intraoperative
1
1994
107
0.120
Why?
Mouth
2
2011
48
0.120
Why?
Photochemotherapy
1
2013
95
0.110
Why?
Pain
1
2015
383
0.110
Why?
Radiation-Sensitizing Agents
1
2012
96
0.110
Why?
Education, Medical, Graduate
1
2016
358
0.110
Why?
Radiotherapy
2
2011
326
0.110
Why?
Survival Analysis
5
2018
1531
0.110
Why?
Lymph Node Excision
1
2013
208
0.110
Why?
Protein Kinase Inhibitors
1
2016
586
0.100
Why?
Chemoradiotherapy, Adjuvant
1
2011
35
0.100
Why?
Chemotherapy, Adjuvant
5
2012
461
0.100
Why?
Deglutition Disorders
2
2011
105
0.100
Why?
Research Design
2
2013
581
0.100
Why?
Tracheotomy
1
2011
18
0.100
Why?
Organ Preservation
1
2011
75
0.100
Why?
Survival Rate
4
2019
1843
0.100
Why?
Genetic Predisposition to Disease
1
2019
2231
0.100
Why?
Speech
1
2010
82
0.100
Why?
Brain Diseases
1
2011
177
0.100
Why?
Agammaglobulinemia
1
2010
20
0.090
Why?
Airway Obstruction
1
2011
108
0.090
Why?
Vocal Cords
1
2009
23
0.090
Why?
Developmental Disabilities
1
2011
192
0.090
Why?
Quality of Life
3
2012
1504
0.090
Why?
Emergency Medical Services
1
2012
195
0.090
Why?
Kaplan-Meier Estimate
4
2013
854
0.090
Why?
Vascular Endothelial Growth Factor A
2
2009
387
0.090
Why?
Cohort Studies
5
2018
2703
0.090
Why?
Genomics
1
2014
678
0.090
Why?
Radiotherapy, High-Energy
1
2008
49
0.090
Why?
Confidence Intervals
4
2018
227
0.090
Why?
Neck Dissection
4
2010
67
0.090
Why?
Enteral Nutrition
2
2020
103
0.090
Why?
Myelitis, Transverse
1
2008
10
0.090
Why?
Submandibular Gland Diseases
1
2008
9
0.090
Why?
Neoplasms, Second Primary
1
2011
250
0.090
Why?
Skin
1
2012
550
0.090
Why?
Military Personnel
1
2009
79
0.090
Why?
Neuromyelitis Optica
1
2008
21
0.080
Why?
Neoadjuvant Therapy
2
2012
308
0.080
Why?
Aortic Aneurysm
1
1988
79
0.080
Why?
Risk Assessment
5
2016
2223
0.080
Why?
Fatal Outcome
2
2019
290
0.080
Why?
Taxoids
1
2007
129
0.080
Why?
Sinus Thrombosis, Intracranial
1
2006
13
0.080
Why?
DNA
1
2012
1271
0.080
Why?
Tinnitus
1
2006
21
0.070
Why?
Incidence
3
2018
1565
0.070
Why?
Headache
1
2006
69
0.070
Why?
Antibodies, Monoclonal
2
2010
1357
0.070
Why?
Prodrugs
2
1996
44
0.070
Why?
Drug Administration Schedule
4
2016
917
0.070
Why?
Dose-Response Relationship, Drug
3
2019
1948
0.070
Why?
Infant, Newborn
1
2011
2322
0.070
Why?
Drug Therapy, Combination
3
1999
883
0.070
Why?
Cisplatin
2
2022
600
0.070
Why?
Bevacizumab
3
2011
276
0.070
Why?
Pregnancy
1
2011
2795
0.060
Why?
Adenocarcinoma
1
2011
1155
0.060
Why?
Gastroesophageal Reflux
2
2009
113
0.060
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2017
104
0.060
Why?
Lamivudine
1
2023
12
0.060
Why?
Heterocyclic Compounds, 3-Ring
1
2023
24
0.060
Why?
Radiotherapy, Adjuvant
3
2010
291
0.060
Why?
Tomography, X-Ray Computed
2
2011
2497
0.060
Why?
Internship and Residency
1
2012
977
0.060
Why?
Remission Induction
2
2016
709
0.060
Why?
Immunohistochemistry
3
2017
1736
0.060
Why?
Alcohol Drinking
2
2018
263
0.050
Why?
Gene Expression Profiling
2
2020
1355
0.050
Why?
Retreatment
2
2012
107
0.050
Why?
Albumins
1
2022
135
0.050
Why?
Pulmonary Surgical Procedures
1
2021
8
0.050
Why?
RNA, Viral
1
2023
324
0.050
Why?
Receptor, Endothelin A
1
2021
22
0.050
Why?
Clinical Trials, Phase II as Topic
2
2013
173
0.050
Why?
Respiratory Function Tests
1
2021
133
0.050
Why?
Endothelial Growth Factors
1
2001
55
0.050
Why?
Lymphokines
1
2001
75
0.050
Why?
Constriction, Pathologic
1
2021
205
0.050
Why?
Periodontal Diseases
1
2000
9
0.050
Why?
Antibodies, Monoclonal, Humanized
3
2011
918
0.050
Why?
Radiography
2
2014
799
0.050
Why?
Lymphoid Tissue
1
2000
57
0.050
Why?
Bronchoscopy
1
2021
144
0.050
Why?
Hyperplasia
1
2000
146
0.050
Why?
Disease Progression
2
2017
1478
0.050
Why?
Feasibility Studies
1
2022
741
0.050
Why?
Carcinoma, Papillary
1
2001
158
0.050
Why?
Clindamycin
2
1999
13
0.050
Why?
Cefuroxime
2
1996
3
0.050
Why?
Tonsillectomy
1
1999
29
0.050
Why?
Benzylamines
1
2019
16
0.040
Why?
Patient-Centered Care
1
2021
197
0.040
Why?
Neoplasms, Squamous Cell
1
2019
19
0.040
Why?
Aortic Rupture
2
1990
53
0.040
Why?
Patient Care Team
1
2021
274
0.040
Why?
Bone Marrow Examination
1
2019
48
0.040
Why?
Antibiotic Prophylaxis
1
1999
72
0.040
Why?
Evidence-Based Medicine
1
2021
422
0.040
Why?
Primary Myelofibrosis
1
2019
56
0.040
Why?
Oral Health
1
2018
11
0.040
Why?
Double-Blind Method
3
2016
1797
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2017
11
0.040
Why?
Myoepithelioma
1
2017
11
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p15
1
2017
24
0.040
Why?
Metals
1
2018
89
0.040
Why?
Laryngectomy
1
2017
26
0.040
Why?
Surgical Wound Infection
2
1999
185
0.040
Why?
Multivariate Analysis
2
2011
988
0.040
Why?
Statistics, Nonparametric
2
2009
305
0.040
Why?
Parotid Gland
1
2017
31
0.040
Why?
Adenocarcinoma, Clear Cell
1
2017
62
0.040
Why?
Mutation
2
2020
3889
0.040
Why?
Biomarkers
1
2023
1654
0.040
Why?
Oncogene Proteins, Fusion
1
2017
129
0.040
Why?
Probability
2
2008
351
0.040
Why?
Otitis Media
1
1996
16
0.040
Why?
Translocation, Genetic
1
2017
265
0.040
Why?
Everolimus
1
2016
40
0.040
Why?
Pyrazoles
1
2017
152
0.040
Why?
Loss of Heterozygosity
1
2016
85
0.040
Why?
Otitis Media with Effusion
1
1995
6
0.040
Why?
Analgesics, Opioid
1
2020
397
0.040
Why?
Cutaneous Fistula
1
1995
13
0.030
Why?
Cellulitis
1
1995
19
0.030
Why?
Magnetic Resonance Imaging
3
2017
3253
0.030
Why?
Cephalosporins
1
1995
22
0.030
Why?
Pyridines
1
2017
305
0.030
Why?
Dissection
1
1995
42
0.030
Why?
Human papillomavirus 18
1
2014
16
0.030
Why?
Costs and Cost Analysis
1
1995
150
0.030
Why?
Sex Factors
1
2018
1038
0.030
Why?
Human papillomavirus 16
1
2014
38
0.030
Why?
Drug Costs
1
1995
61
0.030
Why?
Protein Interaction Maps
1
2014
49
0.030
Why?
Hospital Costs
1
1995
100
0.030
Why?
Administration, Oral
1
2016
685
0.030
Why?
Electromyography
1
1994
183
0.030
Why?
Societies, Medical
1
2017
573
0.030
Why?
Drug Resistance, Neoplasm
1
2017
580
0.030
Why?
Clavulanic Acids
3
1999
3
0.030
Why?
Amoxicillin-Potassium Clavulanate Combination
3
1999
4
0.030
Why?
Amoxicillin
3
1999
13
0.030
Why?
DNA Copy Number Variations
1
2014
171
0.030
Why?
Multicenter Studies as Topic
1
2013
145
0.030
Why?
Electric Stimulation
1
1994
340
0.030
Why?
Age Factors
1
2018
1823
0.030
Why?
Rabbits
1
1994
634
0.030
Why?
Platinum
1
2012
61
0.030
Why?
Phenotype
1
2019
2323
0.030
Why?
Aorta, Abdominal
2
1990
59
0.030
Why?
Organ Sparing Treatments
1
2011
35
0.030
Why?
Length of Stay
1
1995
684
0.030
Why?
Practice Patterns, Physicians'
1
2017
573
0.030
Why?
Supraglottitis
1
2011
3
0.030
Why?
Radiotherapy Planning, Computer-Assisted
1
2012
192
0.030
Why?
Pemetrexed
1
2011
76
0.030
Why?
Glutamates
1
2011
89
0.030
Why?
Antimetabolites, Antineoplastic
1
2012
236
0.020
Why?
Clinical Trials, Phase I as Topic
1
2011
150
0.020
Why?
Genetic Therapy
1
2012
340
0.020
Why?
Leucovorin
1
2010
219
0.020
Why?
Antineoplastic Agents, Phytogenic
1
2012
276
0.020
Why?
Osteoradionecrosis
1
2010
17
0.020
Why?
Guanine
1
2011
206
0.020
Why?
Interferon-alpha
1
2010
232
0.020
Why?
Camptothecin
1
2010
189
0.020
Why?
Deoxycytidine
1
2011
236
0.020
Why?
Postoperative Period
1
2010
305
0.020
Why?
Laryngoscopy
1
2009
45
0.020
Why?
Siblings
1
2010
110
0.020
Why?
Treatment Failure
1
2010
284
0.020
Why?
Dose-Response Relationship, Radiation
1
2009
189
0.020
Why?
Transforming Growth Factor alpha
1
2009
48
0.020
Why?
Postoperative Complications
1
1999
2195
0.020
Why?
Syndrome
1
2010
432
0.020
Why?
Chi-Square Distribution
1
2009
357
0.020
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2009
77
0.020
Why?
Bone Marrow Cells
1
2010
247
0.020
Why?
Arteriosclerosis
1
1988
111
0.020
Why?
Recombinant Proteins
1
2010
1008
0.020
Why?
Hypersensitivity
1
2009
144
0.020
Why?
Bacterial Infections
1
2010
179
0.020
Why?
Lymphatic Metastasis
1
2009
479
0.020
Why?
Neoplasm Metastasis
1
2012
1049
0.020
Why?
Regression Analysis
1
2009
596
0.020
Why?
Autoantibodies
1
2008
257
0.020
Why?
Cranial Sinuses
1
2006
14
0.020
Why?
Odds Ratio
1
2008
670
0.020
Why?
Blood Vessel Prosthesis
1
1988
221
0.020
Why?
Neoplasm Proteins
1
2010
533
0.020
Why?
Comorbidity
1
2009
933
0.020
Why?
Endothelium, Vascular
1
1988
429
0.020
Why?
Cerebrovascular Circulation
1
2006
207
0.020
Why?
Coronary Artery Disease
1
1988
333
0.020
Why?
Prevalence
1
2008
1218
0.020
Why?
Signal Transduction
1
2014
3179
0.020
Why?
Preoperative Care
1
2006
393
0.010
Why?
Algorithms
1
2011
1803
0.010
Why?
Registries
1
2006
687
0.010
Why?
Asthma
1
2009
929
0.010
Why?
Vascular Endothelial Growth Factors
1
2001
57
0.010
Why?
Case-Control Studies
1
2006
1786
0.010
Why?
Ticarcillin
1
1999
1
0.010
Why?
Mouthwashes
1
1999
5
0.010
Why?
Ampicillin
1
1999
15
0.010
Why?
Administration, Topical
1
1999
91
0.010
Why?
Injections, Intravenous
1
1999
241
0.010
Why?
Infant
2
1996
2993
0.010
Why?
Child, Preschool
2
1996
3569
0.010
Why?
Pilot Projects
1
1999
816
0.010
Why?
Animals
2
1994
26005
0.010
Why?
Suspensions
1
1996
6
0.010
Why?
Bacteria
1
1999
432
0.010
Why?
Acute Disease
1
1996
811
0.010
Why?
Back Pain
1
1990
36
0.010
Why?
Hematoma
1
1990
95
0.010
Why?
6-Ketoprostaglandin F1 alpha
1
1988
5
0.010
Why?
Microscopy, Electron, Scanning
1
1988
132
0.010
Why?
Polytetrafluoroethylene
1
1988
73
0.010
Why?
Jugular Veins
1
1988
70
0.010
Why?
Microcirculation
1
1988
103
0.010
Why?
Omentum
1
1988
71
0.010
Why?
Dogs
1
1988
680
0.000
Why?
Aorta
1
1988
274
0.000
Why?
Thrombosis
1
1988
284
0.000
Why?
Blair's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (371)
Explore
_
Co-Authors (47)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_